@misc{schurigt_cathepsin_k_2008, 
author={Schurigt, U.,Hummel, K.M.,Petrow, P.K.,Gajda, M.,Stoeckigt, R.,Middel, P.,Zwerina, J.,Janik, T.,Bernhardt, R.,Schueler, S.,Scharnweber, D.,Beckmann, F.,Saftig, P.,Kollias, G.,Schett, G.,Wiederanders, B.,Braeuer, R.},
title={Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor-transgenic},
year={2008},
howpublished = {journal article},
doi = {https://doi.org/10.1002/art.23224},
abstract = {Cathepsin K is believed to have an eminent role in the pathologic resorption of bone. However, several studies have shown that other proteinases also participate in this process. In order to clarify the contribution of cathepsin K to the destruction of arthritic bone, we applied the human tumor necrosis factor (hTNF)-transgenic mouse model, in which severe polyarthritis characterized by strong osteoclast-mediated bone destruction develops spontaneously.},
note = {Online available at: \url{https://doi.org/10.1002/art.23224} (DOI). Schurigt, U.; Hummel, K.; Petrow, P.; Gajda, M.; Stoeckigt, R.; Middel, P.; Zwerina, J.; Janik, T.; Bernhardt, R.; Schueler, S.; Scharnweber, D.; Beckmann, F.; Saftig, P.; Kollias, G.; Schett, G.; Wiederanders, B.; Braeuer, R.: Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor-transgenic. Arthritis & Rheumatism. 2008. vol. 58, no. 2, 422-434. DOI: 10.1002/art.23224}}